When you linking your Twitter Account Market Wire News Trending Stocks news and your Portfolio Stocks News will automatically tweet from your Twitter account.
Be alerted of any news about your stocks and see what other stocks are trending.
HRTX - European advisory group backs Heron drug for post-op pain
Heron Therapeutics Inc.
The European Medicines Agency's advisory group CHMP has adopted a positive opinion recommending approval of Heron Therapeutics' (NASDAQ:HRTX) Zynrelef (formerly HTX-011), a fixed-dose combination of local anesthetic bupivacaine and nonsteroidal anti-inflammatory med meloxicam, for the treatment of postoperative pain.
More news on: Heron Therapeutics, Inc., Healthcare stocks news, Stocks on the move,